This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Agilent Technologies Awards Russell Varian Prize For Innovation In NMR To Dr. Lucio Frydman

Stocks in this article: A

Agilent Technologies Inc. (NYSE: A) today announced that the 2013 Russell Varian Prize for Innovation in Nuclear Magnetic Resonance has been awarded to Dr. Lucio Frydman, professor and Kimmel Fellow at the Weizmann Institute of Science in Rehovot, Israel. Dr. Frydman’s seminal paper, “The Acquisition of Multidimensional NMR Spectra within a Single Scan,” introduces a unique technique for recording multidimensional NMR spectra in a single scan, and describes the theoretical basis and experimental realization of this ultrafast NMR methodology.

The paper is based on an idea by Dr. Frydman and the contributions of two additional authors. It was published in 2002 in PNAS—Proceedings of the National Academy of Sciences of the United States of America.

“We are very pleased to present the prize to Dr. Frydman, who has been a key innovator for NMR methodology for both solution and solid-state NMR,” said Regina Schuck, Ph.D., general manager of Agilent’s Research Products Division.

“Dr. Frydman’s ultrafast NMR technique significantly expands NMR methodology for the study of fast processes, including chemical reactions, biochemical pathways and protein folding, which are inaccessible on the time scale of conventional multidimensional NMR methods or by other biophysical methods.”

“Receiving this accolade was particularly moving, for multiple converging reasons,” said Dr. Frydman. “On one hand there is the personality of Russell Varian: as entrepreneur, as scientist, as a human being—in all senses, a true ‘mensch.’ In addition there is the outstanding roster of previous awardees, which includes some of the most distinguished founders and developers of what magnetic resonance has become today. Overall, an inspiring honor.”

The Russell Varian Prize for Innovation in Nuclear Magnetic Resonance honors the memory of the pioneer behind the first commercial nuclear magnetic resonance spectrometers and cofounder of Varian Associates, which is now part of Agilent. The prize is awarded to researchers based on a single innovative contribution (a single paper, patent, lecture or piece of hardware) that has demonstrated broad impact on the state of the art in NMR and original contributions that have triggered important advancements in scientific technology.

The complete article may be viewed on the PNAS website: The Acquisition of Multidimensional NMR Spectra within a Single Scan, Lucio Frydman, Tali Scherf, and Adonis Lupulescu, PNAS 2002 99 (25) 15858-15862.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company and a technology leader in chemical analysis, life sciences, diagnostics, electronics and communications. The company’s 20,500 employees serve customers in more than 100 countries. Agilent had revenues of $6.9 billion in fiscal 2012. Information about Agilent is available at www.agilent.com.

NOTE TO EDITORS: Further technology, corporate citizenship and executive news is available at www.agilent.com/go/news.



1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs